Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) Shares Outstanding (EOP): 123 Mil (As of Mar. 2026)


BSP:PFRM3 Profarma Distribuidora De Produtos Farmaceuticos SA BSP:PFRM3
75 GF Score
Price R$6.72
GF Value R$8.03
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Profarma Distribuidora De Produtos Farmaceuticos Shares Outstanding (EOP)?

Profarma Distribuidora De Produtos Farmaceuticos BSP:PFRM3 +0.15% 75 Shares Outstanding (EOP) is 123 Mil as of Mar. 2026. GuruFocus rates BSP:PFRM3 with a GF Score™ of 75/100 and a GF Value™ of R$8.03 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Profarma Distribuidora De Produtos Farmaceuticos's shares outstanding for the quarter that ended in Mar. 2026 was 123 Mil.

Profarma Distribuidora De Produtos Farmaceuticos's quarterly shares outstanding stayed the same from Dec. 2025 (123 Mil) to Mar. 2026 (123 Mil).

Profarma Distribuidora De Produtos Farmaceuticos's annual shares outstanding stayed the same from Dec. 2024 (123 Mil) to Dec. 2025 (123 Mil).


Profarma Distribuidora De Produtos Farmaceuticos  (BSP:PFRM3) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Profarma Distribuidora De Produtos Farmaceuticos Shares Outstanding (EOP) Related Terms


Profarma Distribuidora De Produtos Farmaceuticos Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Profarma Distribuidora De Produtos Farmaceuticos's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Profarma Distribuidora De Produtos Farmaceuticos Shares Outstanding (EOP) Chart

Profarma Distribuidora De Produtos Farmaceuticos Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 122.61 122.61 122.61 122.61 122.61

Profarma Distribuidora De Produtos Farmaceuticos Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 122.61 122.61 122.61 122.61 122.61

BSP:PFRM3 vs MCK, CAH, COR: Shares Outstanding (EOP) Comparison

For the Medical Distribution subindustry, Profarma Distribuidora De Produtos Farmaceuticos's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Profarma Distribuidora De Produtos Farmaceuticos Shares Outstanding (EOP) vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Profarma Distribuidora De Produtos Farmaceuticos's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Profarma Distribuidora De Produtos Farmaceuticos's Shares Outstanding (EOP) falls into.


BSP:PFRM3
75GF Score
Profarma Distribuidora De Produtos Farmaceuticos SA BSP:PFRM3
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Profarma Distribuidora De Produtos Farmaceuticos Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 123 Mil mean?
Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) has a Shares Outstanding (EOP) of 123 Mil as of Mar. 2026. The total shares a company has outstanding, at period-end. View historical data on Profarma Distribuidora De Produtos Farmaceuticos and its competitors.
Is Profarma Distribuidora De Produtos Farmaceuticos' Shares Outstanding (EOP) too high?
Profarma Distribuidora De Produtos Farmaceuticos' current Shares Outstanding (EOP) is 123 Mil. Overall, Profarma Distribuidora De Produtos Farmaceuticos has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Profarma Distribuidora De Produtos Farmaceuticos' Shares Outstanding (EOP) compare to MCK and CAH?
Profarma Distribuidora De Produtos Farmaceuticos' Shares Outstanding (EOP) of 123 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Medical Distribution company?
A good Shares Outstanding (EOP) depends on the Medical Distribution industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Profarma Distribuidora De Produtos Farmaceuticos and its competitors. Profarma Distribuidora De Produtos Farmaceuticos's current Shares Outstanding (EOP) is 123 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Profarma Distribuidora De Produtos Farmaceuticos stock overvalued right now?
Based on GuruFocus' analysis, Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$8.03, compared to a current price of R$6.72 — trading 16.3% below its estimated fair value. The current Shares Outstanding (EOP) is 123 Mil. Profarma Distribuidora De Produtos Farmaceuticos' overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3), the current Shares Outstanding (EOP) is 123 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Profarma Distribuidora De Produtos Farmaceuticos (BSP:PFRM3) Overvalued in 2026?

Based on GuruFocus' analysis, Profarma Distribuidora De Produtos Farmaceuticos stock appears to be undervalued. The current stock price of R$6.72 is trading 16.3% below its estimated GF Value™ of R$8.03. GuruFocus considers Profarma Distribuidora De Produtos Farmaceuticos to be Modestly Undervalued.

Key valuation signals for BSP:PFRM3:

  • Shares Outstanding (EOP): 123 Mil
  • GF Value™: R$8.03 vs. price of R$6.72 (16.3% below fair value)
  • GF Score™: 75/100 with 5 warning signs

No single metric tells the full story. See the BSP:PFRM3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Profarma Distribuidora De Produtos Farmaceuticos Business Description

Address Avenida Ayrton Senna, 2.150, Bloco P, 3rd floor andar, Barra da Tijuca, RJ, BRA, 22775-900
Profarma Distribuidora De Produtos Farmaceuticos SA is a Brazil-based company. It is engaged in wholesale and distribution of pharmaceuticals, cosmetics and similar products, and toiletries. Profarma also holds interests in other companies, regardless of their business sector. The company through its logistics department distributes products in the South, Southeast, Northeast and Center-West regions of Brazil. The firm operates in the pharmaceutical distribution, hospital and specialty, retail segments.
75GF Score

Get the complete analysis for BSP:PFRM3

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$6.72
Price
R$8.03
GF Value